应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
IBD Inspire Corporate Bond ETF
盘前交易 07-11 05:31:39 EDT
23.91
+0.01
+0.02%
最高
23.98
最低
23.86
成交量
5.25万
今开
23.89
昨收
23.91
日振幅
0.50%
总市值
3.92亿
流通市值
3.92亿
总股本
1,640万
成交额
125.51万
换手率
0.32%
流通股本
1,640万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
艾伯维挥起拳头
新康界 · 05-25
艾伯维挥起拳头
Organovo Holdings, Inc.盘中异动 早盘股价大跌7.85%报1.59美元
市场透视 · 04-21
Organovo Holdings, Inc.盘中异动 早盘股价大跌7.85%报1.59美元
Organovo Holdings, Inc.盘中异动 股价大跌5.12%报1.58美元
市场透视 · 04-17
Organovo Holdings, Inc.盘中异动 股价大跌5.12%报1.58美元
Organovo Holdings, Inc.盘中异动 早盘股价大涨5.12%报1.75美元
市场透视 · 04-16
Organovo Holdings, Inc.盘中异动 早盘股价大涨5.12%报1.75美元
Organovo Holdings, Inc.盘中异动 股价大涨6.59%报1.78美元
市场透视 · 04-15
Organovo Holdings, Inc.盘中异动 股价大涨6.59%报1.78美元
Organovo Holdings, Inc.盘中异动 下午盘快速下跌6.37%报0.422美元
市场透视 · 03-10
Organovo Holdings, Inc.盘中异动 下午盘快速下跌6.37%报0.422美元
Organovo Holdings, Inc.盘中异动 快速下挫6.10%
市场透视 · 03-05
Organovo Holdings, Inc.盘中异动 快速下挫6.10%
艾伯维杀入减重赛道 寻找下一个“药王”？
新京报 · 03-04
艾伯维杀入减重赛道 寻找下一个“药王”？
Organovo Holdings, Inc.股价重挫10.77% 市值跌109.04万美元
市场透视 · 03-03
Organovo Holdings, Inc.股价重挫10.77% 市值跌109.04万美元
Organovo Holdings, Inc.盘中异动 早盘大幅跳水5.55%
市场透视 · 02-28
Organovo Holdings, Inc.盘中异动 早盘大幅跳水5.55%
Organovo Holdings, Inc.盘中异动 早盘股价大跌8.09%
市场透视 · 02-27
Organovo Holdings, Inc.盘中异动 早盘股价大跌8.09%
Organovo Holdings, Inc.股价拉升11.82% 市值涨292.98万美元
市场透视 · 02-26
Organovo Holdings, Inc.股价拉升11.82% 市值涨292.98万美元
Organovo Holdings, Inc.股价上涨238.75% 市值涨5209.05万美元
市场透视 · 02-25
Organovo Holdings, Inc.股价上涨238.75% 市值涨5209.05万美元
Organovo Holdings, Inc.盘中异动 股价大跌5.15%报0.350美元
市场透视 · 02-24
Organovo Holdings, Inc.盘中异动 股价大跌5.15%报0.350美元
Organovo Holdings, Inc.盘中异动 股价大跌5.51%
市场透视 · 02-19
Organovo Holdings, Inc.盘中异动 股价大跌5.51%
Organovo Holdings, Inc.盘中异动 股价大跌5.96%报0.363美元
市场透视 · 02-18
Organovo Holdings, Inc.盘中异动 股价大跌5.96%报0.363美元
Organovo Holdings, Inc.盘中异动 股价大涨5.82%报0.400美元
市场透视 · 02-14
Organovo Holdings, Inc.盘中异动 股价大涨5.82%报0.400美元
Organovo Holdings, Inc.盘中异动 早盘快速拉升5.02%
市场透视 · 02-13
Organovo Holdings, Inc.盘中异动 早盘快速拉升5.02%
MNC年报扫描｜巨头“厮杀” 国产“逐鹿”：自免领域5大单品狂揽近530亿美元
21世纪经济报道 · 02-07
MNC年报扫描｜巨头“厮杀” 国产“逐鹿”：自免领域5大单品狂揽近530亿美元
【礼来(LLY.US)IL-23p19单抗mirikizumab获批克罗恩病新适应症】1月15日，礼来(LLY.US)宣布，其IL-23p19单抗mirikizumab(Omvoh)已获FDA批准第2项适应症，用于治疗成人中度至重度活动性克罗恩病。Mirikizumab继2023年10月被批准为治疗中度至重度活动性成人溃疡性结肠炎(UC)的同类首创疗法之后，现在又被批准用于治疗两种类型的炎症性肠病(IBD)。
金融界 · 01-16
【礼来(LLY.US)IL-23p19单抗mirikizumab获批克罗恩病新适应症】1月15日，礼来(LLY.US)宣布，其IL-23p19单抗mirikizumab(Omvoh)已获FDA批准第2项适应症，用于治疗成人中度至重度活动性克罗恩病。Mirikizumab继2023年10月被批准为治疗中度至重度活动性成人溃疡性结肠炎(UC)的同类首创疗法之后，现在又被批准用于治疗两种类型的炎症性肠病(IBD)。
加载更多
公司概况
公司名称：
Inspire Corporate Bond ETF
所属市场：
ARCA
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"IBD","market":"US","secType":"STK","nameCN":"Inspire Corporate Bond ETF","latestPrice":23.91,"timestamp":1752177600000,"preClose":23.905,"halted":0,"volume":52501,"delay":0,"floatShares":16400000,"shares":16400000,"eps":0,"marketStatus":"盘前交易","change":0.005,"latestTime":"07-11 05:31:39 EDT","open":23.89,"high":23.98,"low":23.86,"amount":1255120.144095,"amplitude":0.00502,"askPrice":29.14,"askSize":100,"bidPrice":19.07,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752240600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":23.92,"sharesOutstanding":16400000,"nav":23.88,"aum":391643939.55,"dividendRate":0.042242,"bidAskSpread":0.001765,"postHourTrading":{"tag":"盘后","latestPrice":23.59,"preClose":23.91,"latestTime":"18:14 EDT","volume":140,"amount":3304.52,"timestamp":1752185656136},"volumeRatio":0.5422353251083507},"requestUrl":"/m/hq/s/IBD","defaultTab":"news","newsList":[{"id":"2538211551","title":"艾伯维挥起拳头","url":"https://stock-news.laohu8.com/highlight/detail?id=2538211551","media":"新康界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538211551?lang=zh_cn&edition=full","pubTime":"2025-05-25 10:59","pubTimestamp":1748141979,"startTime":"0","endTime":"0","summary":"艾伯维，作为昔日药王的拥有者，面临专利悬崖压境，举起拳头挥向新战场！表1.艾伯维免疫领域核心产品这一颓势直接拖累艾伯维2024年净利润下跌12.03%。表2.艾伯维肿瘤领域核心产品然而，随着百济神州的泽布替尼、阿斯利康的阿卡替尼等二代BTK抑制剂通过“头对头”试验证明更优疗效与安全性，伊布替尼市场份额被快速瓜分。02频繁动刀为了走出“泥潭”，艾伯维在肿瘤领域多次挥刀，转而瞄准自免与神经科学等赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525114119a48b5df4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525114119a48b5df4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","LU2129689605.HKD","IE00B19Z3B42.SGD","LU0211327993.USD","LU0820561909.HKD","IBD","LU1093756325.SGD","CF","LU2087621335.USD","LU0122379950.USD","LU2237443895.HKD","ORR","LU1244550577.SGD","IE00B4R5TH58.HKD","BK4093","ABBV","LU1244550221.USD","LU0861579265.USD","BK4139","LU2237443382.USD","LU1934455863.HKD","IE0002270589.USD","SG9999015986.USD","PROC","LU1585245621.USD","LU0234572021.USD","LU1162221912.USD","OS","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","IE0009355771.USD","LU0203347892.USD","LU0029864427.USD","IE00BDGV0183.EUR","LU0949170772.SGD","SG9999015945.SGD","SG9999003800.SGD","IE00B3PB1722.GBP","LU0965509101.SGD","LU0912757837.SGD","LU1983299246.USD","LU2133065610.SGD","SG9999015952.SGD","LU0310800379.SGD","LU1989772923.USD","LU2112291526.USD","BK4097","PFS","LU1551013425.SGD","LU1244550494.USD"],"gpt_icon":0},{"id":"2529905802","title":"Organovo Holdings, Inc.盘中异动 早盘股价大跌7.85%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529905802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529905802?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:47","pubTimestamp":1745243239,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时47分，Organovo Holdings, Inc.股票出现波动，股价大幅下挫7.85%。截至发稿，该股报1.59美元/股，成交量8949股，换手率0.50%，振幅2.33%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214719aa2c73fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214719aa2c73fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONVO","VIVS","BK4139","IBD"],"gpt_icon":0},{"id":"2528450207","title":"Organovo Holdings, Inc.盘中异动 股价大跌5.12%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528450207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528450207?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:35","pubTimestamp":1744896909,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时35分，Organovo Holdings, Inc.股票出现异动，股价急速下跌5.12%。截至发稿，该股报1.58美元/股，成交量1.9508万股，换手率1.08%，振幅2.71%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213510a6be0b13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213510a6be0b13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIVS","BK4139","ONVO","IBD"],"gpt_icon":0},{"id":"2527961244","title":"Organovo Holdings, Inc.盘中异动 早盘股价大涨5.12%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527961244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527961244?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:58","pubTimestamp":1744811903,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时58分，Organovo Holdings, Inc.股票出现异动，股价快速上涨5.12%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416215823aa2c7183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416215823aa2c7183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","BK4139","ONVO"],"gpt_icon":0},{"id":"2527944325","title":"Organovo Holdings, Inc.盘中异动 股价大涨6.59%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527944325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527944325?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:18","pubTimestamp":1744726730,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时18分，Organovo Holdings, Inc.股票出现异动，股价大幅拉升6.59%。截至发稿，该股报1.78美元/股，成交量4.1376万股，换手率2.30%，振幅3.96%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041522185094d636f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041522185094d636f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONVO","IBD"],"gpt_icon":0},{"id":"2518420501","title":"Organovo Holdings, Inc.盘中异动 下午盘快速下跌6.37%报0.422美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518420501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518420501?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:05","pubTimestamp":1741626341,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时05分，Organovo Holdings, Inc.股票出现异动，股价大幅下挫6.37%。截至发稿，该股报0.422美元/股，成交量27.3231万股，换手率1.57%，振幅8.70%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311010542abf34a26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311010542abf34a26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONVO","BK4139","IBD"],"gpt_icon":0},{"id":"2517908945","title":"Organovo Holdings, Inc.盘中异动 快速下挫6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517908945?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:43","pubTimestamp":1741185821,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时43分，Organovo Holdings, Inc.股票出现波动，股价急速下挫6.10%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224341963adf65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224341963adf65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","BK4139","ONVO"],"gpt_icon":0},{"id":"2516260096","title":"艾伯维杀入减重赛道 寻找下一个“药王”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2516260096","media":"新京报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516260096?lang=zh_cn&edition=full","pubTime":"2025-03-04 18:00","pubTimestamp":1741082458,"startTime":"0","endTime":"0","summary":"艾伯维还是杀入了减重赛道。美国时间3月3日，艾伯维宣布与Gubra公司达成许可协议，共同开发用于治疗肥胖症的潜在同类最佳长效胰淀素类似物，交易总额最高可达22亿美元。当前减重赛道火热，2024年两款全球畅销减重药物更是合计卖出了457.42亿美元。自旗下修美乐因专利到期等因素销售开始下滑后，艾伯维业绩受到影响，近年来也在频频对外合作，提振业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503043336126264.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503043336126264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBD"],"gpt_icon":0},{"id":"2516634704","title":"Organovo Holdings, Inc.股价重挫10.77% 市值跌109.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634704?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:30","pubTimestamp":1741012250,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时30分，Organovo Holdings, Inc.股票出现异动，股价大幅下跌10.77%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032230509637ab9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032230509637ab9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONVO","IBD","BK4139"],"gpt_icon":1},{"id":"2514583373","title":"Organovo Holdings, Inc.盘中异动 早盘大幅跳水5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514583373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514583373?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:51","pubTimestamp":1740754266,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时51分，Organovo Holdings, Inc.股票出现异动，股价急速下挫5.55%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822510696341eaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822510696341eaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","ONVO","BK4139"],"gpt_icon":1},{"id":"2514385603","title":"Organovo Holdings, Inc.盘中异动 早盘股价大跌8.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385603?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:37","pubTimestamp":1740667027,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时37分，Organovo Holdings, Inc.股票出现波动，股价急速下挫8.09%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272237079632b21c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272237079632b21c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONVO","IBD","BK4139"],"gpt_icon":1},{"id":"2514518578","title":"Organovo Holdings, Inc.股价拉升11.82% 市值涨292.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514518578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514518578?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580349,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Organovo Holdings, Inc.股票出现异动，股价快速拉升11.82%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2837.58%、119.45%、90.45%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为35.59%、16.86%、14.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223230a254f6af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223230a254f6af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","BK4139","ONVO"],"gpt_icon":0},{"id":"2514090481","title":"Organovo Holdings, Inc.股价上涨238.75% 市值涨5209.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090481?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493865,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Organovo Holdings, Inc.股票出现异动，股价急速上涨238.75%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为746.23%、508.78%、459.72%，振幅较大的相关个股有Organovo Holdings, Inc.、Igm Biosciences, Inc.、Bicara Therapeutics Inc.，振幅分别为8.13%、7.46%、5.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223105abdc7da6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223105abdc7da6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","BK4139","ONVO"],"gpt_icon":0},{"id":"2514670511","title":"Organovo Holdings, Inc.盘中异动 股价大跌5.15%报0.350美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514670511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514670511?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:35","pubTimestamp":1740429350,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时35分，Organovo Holdings, Inc.股票出现波动，股价快速跳水5.15%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043550962ee007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043550962ee007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBD","ONVO"],"gpt_icon":0},{"id":"2512480684","title":"Organovo Holdings, Inc.盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512480684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512480684?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:31","pubTimestamp":1739986261,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时31分，Organovo Holdings, Inc.股票出现波动，股价快速下跌5.51%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220013101988b4e5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220013101988b4e5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBD","ONVO"],"gpt_icon":0},{"id":"2512612521","title":"Organovo Holdings, Inc.盘中异动 股价大跌5.96%报0.363美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512612521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512612521?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:25","pubTimestamp":1739892328,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时25分，Organovo Holdings, Inc.股票出现波动，股价大幅下挫5.96%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218232528a24ab8fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218232528a24ab8fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONVO","BK4139","IBD"],"gpt_icon":0},{"id":"2511137666","title":"Organovo Holdings, Inc.盘中异动 股价大涨5.82%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511137666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511137666?lang=zh_cn&edition=full","pubTime":"2025-02-15 02:04","pubTimestamp":1739556283,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日02时04分，Organovo Holdings, Inc.股票出现波动，股价大幅上涨5.82%。截至发稿，该股报0.400美元/股，成交量8.5386万股，换手率0.56%，振幅6.08%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150204439885bb0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150204439885bb0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONVO","IBD"],"gpt_icon":0},{"id":"2511243345","title":"Organovo Holdings, Inc.盘中异动 早盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511243345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511243345?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:43","pubTimestamp":1739461383,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时43分，Organovo Holdings, Inc.股票出现波动，股价急速上涨5.02%。Organovo Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Organovo Holdings, Inc.公司简介：Organovo Holdings Inc是一家生物技术公司，专注于开发 FXR314 用于炎症性肠病，包括溃疡性结肠炎，其基础是在三维人体组织中展示了临床前景以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213234303abcdc059&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213234303abcdc059&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBD","ONVO"],"gpt_icon":0},{"id":"2509791469","title":"MNC年报扫描｜巨头“厮杀” 国产“逐鹿”：自免领域5大单品狂揽近530亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509791469","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509791469?lang=zh_cn&edition=full","pubTime":"2025-02-07 16:39","pubTimestamp":1738917574,"startTime":"0","endTime":"0","summary":"随着跨国药企（MNC）陆续披露2024年业绩，21世纪经济报道记者初步统计发现，自免领域的营收排名中，赛诺菲的度普利尤单抗、艾伯维的利生奇珠单抗和阿达木单抗、强生的乌司奴单抗、罗氏的奥瑞利珠单抗位居前5，年内销售额合计529.31亿美元。在这5款产品中，度普利尤单抗作为全球首个获批上市的IL-4Rα靶向单抗，凭借不断拓宽的适应症，成为全球“自免新王”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502073313516026.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502073313516026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4116","IBD","CD"],"gpt_icon":0},{"id":"2503916699","title":"【礼来(LLY.US)IL-23p19单抗mirikizumab获批克罗恩病新适应症】1月15日，礼来(LLY.US)宣布，其IL-23p19单抗mirikizumab(Omvoh)已获FDA批准第2项适应症，用于治疗成人中度至重度活动性克罗恩病。Mirikizumab继2023年10月被批准为治疗中度至重度活动性成人溃疡性结肠炎(UC)的同类首创疗法之后，现在又被批准用于治疗两种类型的炎症性肠病(IBD)。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916699","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503916699?lang=zh_cn&edition=full","pubTime":"2025-01-16 21:15","pubTimestamp":1737033339,"startTime":"0","endTime":"0","summary":"1月15日，礼来(LLY.US)宣布，其IL-23p19单抗mirikizumab(Omvoh)已获FDA批准第2项适应症，用于治疗成人中度至重度活动性克罗恩病。Mirikizumab继2023年10月被批准为治疗中度至重度活动性成人溃疡性结肠炎(UC)的同类首创疗法之后，现在又被批准用于治疗两种类型的炎症性肠病(IBD)。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/16211547534225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE0004445239.USD","LU0256863811.USD","LU2063271972.USD","LU0006306889.USD","LU1023059063.AUD","LU2491049909.HKD","LU1983299246.USD","BK4585","SGXZ31699556.SGD","IBD","LU0820561818.USD","GB00BDT5M118.USD","LU1061106388.HKD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU2461242641.AUD","LU1069344957.HKD","LU2237438978.USD","LU2237443978.SGD","LU2237443465.HKD","LU2361045086.USD","LU1974910355.USD","LU1035775433.USD","LU1057294990.SGD","LU2264538146.SGD","LU0106261372.USD","LU0672654240.SGD","LU1712237335.SGD","SG9999001176.SGD","LU0320765059.SGD","SG9999001176.USD","LU1988902786.USD","LU0385154629.USD","LU0058720904.USD","LU0823416689.USD","LU0079474960.USD","LU0203202063.USD","LU2112291526.USD","LU2491050071.SGD","LU0122379950.USD","LLY","IE0002141913.USD","LU0109391861.USD","LU0094547139.USD","LU2237443549.SGD","BK4516","LU2023250504.SGD","IE00BK4W5L77.USD","LU0820561909.HKD","SGXZ99366536.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inspireetf.com/etf/inspire-corporate-bond-impact-etf/","stockEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.0183},{"period":"6month","weight":0.0253},{"period":"1year","weight":0.0179},{"period":"ytd","weight":0.0201}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.001994},{"month":2,"riseRate":0.375,"avgChangeRate":-0.006415},{"month":3,"riseRate":0.375,"avgChangeRate":-0.009316},{"month":4,"riseRate":0.375,"avgChangeRate":0.000132},{"month":5,"riseRate":0.75,"avgChangeRate":0.005151},{"month":6,"riseRate":0.625,"avgChangeRate":0.002487},{"month":7,"riseRate":0.75,"avgChangeRate":0.005606},{"month":8,"riseRate":0.5,"avgChangeRate":0.000986},{"month":9,"riseRate":0.125,"avgChangeRate":-0.009652},{"month":10,"riseRate":0.25,"avgChangeRate":-0.006567},{"month":11,"riseRate":0.5,"avgChangeRate":0.008591},{"month":12,"riseRate":0.375,"avgChangeRate":0.001525}],"exchange":"ARCA","name":"Inspire Corporate Bond ETF","nameEN":"Inspire Corporate Bond ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inspire Corporate Bond ETF(IBD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inspire Corporate Bond ETF(IBD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inspire Corporate Bond ETF,IBD,Inspire Corporate Bond ETF股票,Inspire Corporate Bond ETF股票老虎,Inspire Corporate Bond ETF股票老虎国际,Inspire Corporate Bond ETF行情,Inspire Corporate Bond ETF股票行情,Inspire Corporate Bond ETF股价,Inspire Corporate Bond ETF股市,Inspire Corporate Bond ETF股票价格,Inspire Corporate Bond ETF股票交易,Inspire Corporate Bond ETF股票购买,Inspire Corporate Bond ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inspire Corporate Bond ETF(IBD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inspire Corporate Bond ETF(IBD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}